Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Xeris Biopharma Holdings (XERS) Shares Repurchased (2025)

Xeris Biopharma Holdings (XERS) has disclosed Shares Repurchased for 1 consecutive years, with $12.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Shares Repurchased changed N/A year-over-year to $12.0 million, compared with a TTM value of $15.1 million through Dec 2025, changed N/A, and an annual FY2025 reading of $15.1 million, changed N/A over the prior year.
  • Shares Repurchased was $12.0 million for Q2 2025 at Xeris Biopharma Holdings, up from $3.2 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $12.0 million in Q2 2025 and bottomed at $3.2 million in Q1 2025.